Research Background In preclinical research settings, DSIP has been examined across laboratory models, often in the context of: Neuropeptide and hypothalamic signalling studies Sleep-wake cycle and circadian rhythm research models Stress-response and neuroendocrine pathway investigations Published research summaries and references can be accessed via public scientific databases such as PubMed
The Root Cause Triad: Immune Dysregulation, Gut Dysfunction, and Inflammation Foundational therapies can struggle to break this self-perpetuating cycle, where gut health, inflammation, and immune response are all linked
The preclinical safety profile appears favorable, with the peptide showing no toxicity in animal studies, but this does not guarantee safety in immunocompromised humans
Conditions that affect the gut, like Crohns disease or celiac disease, can damage the intestinal lining, making it difficult for B12 to pass into your bloodstream